[HTML][HTML] Overview and countermeasures of cancer burden in China

Y Wang, Q Yan, C Fan, Y Mo, Y Wang, X Li… - Science China Life …, 2023 - Springer
Cancer is one of the leading causes of human death worldwide. Treatment of cancer
exhausts significant medical resources, and the morbidity and mortality caused by cancer is …

[HTML][HTML] Effects of cancer on patients with COVID-19: a systematic review and meta-analysis of 63,019 participants

L Yang, P Chai, J Yu, X Fan - Cancer Biology & Medicine, 2021 - ncbi.nlm.nih.gov
Objective: Patients with underlying diseases are more vulnerable to coronavirus disease
2019 (COVID-19). The purpose of this study was to investigate cancer incidence in patients …

[HTML][HTML] Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective …

L Monin, AG Laing, M Muñoz-Ruiz… - The Lancet …, 2021 - thelancet.com
Background The efficacy and safety profiles of vaccines against SARS-CoV-2 in patients
with cancer is unknown. We aimed to assess the safety and immunogenicity of the …

Knowledge about, attitude and acceptance towards, and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China: A cross …

J Hong, X Xu, J Yang, J Zheng, S Dai, J Zhou… - Journal of integrative …, 2022 - Elsevier
Objective The coronavirus disease 2019 (COVID-19) pandemic has had a serious impact on
health all over the world. Cancer patient, whose immunity is often compromised, faces a …

Association of COVID-19 with comorbidities: An update

S Chatterjee, LV Nalla, M Sharma… - ACS Pharmacology & …, 2023 - ACS Publications
Coronavirus disease (COVID-19) is caused by severe acute respiratory syndrome-
coronavirus-2 (SARS-CoV-2) which was identified in Wuhan, China in December 2019 and …

[HTML][HTML] Safety and tolerability of SARS-CoV2 emergency-use authorized vaccines for allogeneic hematopoietic stem cell transplant recipients

H Ali, D Ngo, A Aribi, S Arslan, S Dadwal… - … and cellular therapy, 2021 - Elsevier
The safety and efficacy of the severe acute respiratory syndrome coronavirus-2 (SARS-
CoV2) emergency-use authorized (EUA) vaccines have been confirmed in the general …

[HTML][HTML] Investigating the aggressiveness of the COVID-19 Omicron variant and suggestions for possible treatment options

MD Mohiuddin, K Kasahara - Respiratory Medicine, 2022 - Elsevier
The COVID-19 pandemic has put a strain on all the healthcare systems around the world.
The World Health Organization (WHO) stated that the “highly mutated” Omicron variant …

[HTML][HTML] Links between infections, lung cancer, and the immune system

L Budisan, O Zanoaga, C Braicu, R Pirlog… - International journal of …, 2021 - mdpi.com
Lung cancer is the leading disease of cancer-related deaths worldwide. Since the beginning
of the 20th century, various infectious agents associated with lung cancer have been …

Interim results of the safety and immune-efficacy of 1 versus 2 doses of COVID-19 vaccine BNT162b2 for cancer patients in the context of the UK vaccine priority …

L Monin-Aldama, AG Laing, M Muñoz-Ruiz… - MedRxiv, 2021 - medrxiv.org
Background The efficacy and safety profile of vaccines against severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) have not been definitively established in …

Exercise oncology during and beyond the COVID-19 pandemic: Are virtually supervised exercise interventions a sustainable alternative?

P Gonzalo-Encabo, RL Wilson, DW Kang… - Critical reviews in …, 2022 - Elsevier
During the COVID-19 pandemic, new challenges are presented in clinical research settings
to increase exercise levels, particularly in vulnerable populations such as cancer survivors …